Clinical Trials of Recombinant Factor VIII
Gilbert White(Thiel College), Harold R. Roberts(Washington University in St. Louis), Joseph E. Addiego(Hemophilia Center of Western Pennsylvania), Bryan Lewis, Campbell W. McMillan(University of North Carolina at Chapel Hill), Jonathon C. Goldsmith, Henry S. Kingdon(Baxter (United States)), Craig M. Kessler(Georgetown University), M. Morfini, Edward D. Gomperts(Children's Hospital of Los Angeles), C. Thomas Kisker(Hemophilia Center of Western Pennsylvania), Martin L. Lee, Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Joan Cox Gill(American Red Cross), S Courter, I. Scharrer(Goethe University Frankfurt), Piero M. Mannucci, H.‐H. Brackmann, Jeanne M. Lusher(Science Factory), Doreen B. Brettler(University of Massachusetts Chan Medical School), W. Keith Hoots, Y. Laurian(American Red Cross)
Cited by 2
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k